- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT07597980
Lifestyle Intervention to Improve Muscle Function in Older Adults
1 september 2026 uppdaterad av: Candida Rebello, Pennington Biomedical Research Center
The goal of this randomized controlled two-arm trial is to determine the effect of a diet and exercise intervention for 12 weeks on body composition, muscle function, and energy balance in 80 adults aged 50 years and over with obesity and insulin resistance.
The main questions the trial aims to answer are: Will 12 weeks of a structured nutrition plan + exercise reduce fat mass, improve muscle function, and increase energy deficit compared to the usual diet + exercise.
The hypothesis is that 12 weeks of a structured nutrition plan + exercise will reduce fat mass, improve muscle function, and produce greater energy deficit than the usual diet + exercise.
Participants will be provided with all meals for 12 weeks and will exercise at the Center under supervision three times each week.
Pre and post-intervention, body composition, physical function, and energy deficit will be measured.
Studieöversikt
Status
Rekrytering
Betingelser
Intervention / Behandling
Detaljerad beskrivning
In the United States nearly one third of adults over 60 years of age have sarcopenic obesity which encompasses the combined effect of muscle impairment and obesity.
A strategy that addresses the combined effect of muscle impairment and obesity while modulating muscle mass and composition is an unanswered challenge.
This 12-week study will evaluate the effects of a structured nutrition plan combined with an exercise program on body fat and muscle mass, lower-extremity function (Short Physical Performance Battery), muscle strength (handgrip and knee strength), and daily caloric intake.
The study will enroll adults aged 50 years and older with obesity (body mass index ≥ 30 kg/m²) and insulin resistance as indicated by a homeostasis model assessment of insulin resistance (HOMA-IR) score ≥ 3. Subjects will be randomly allocated to receive the structured nutrition plan and exercise intervention or to their usual diet and exercise in equal numbers (40 per group).
The study will enrich our understanding of the physiological adaptations necessary for effective lifestyle interventions to improve muscle function.
Studietyp
Interventionell
Inskrivning (Beräknad)
80
Fas
- Inte tillämpbar
Kontakter och platser
Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.
Studiekontakt
- Namn: Candida J Rebello, PhD, RD
- Telefonnummer: 12257633159
- E-post: Candida.Rebello@pbrc.edu
Studera Kontakt Backup
- Namn: Reilly Roberts A Project Manager, MS
- Telefonnummer: 225-763-2854
- E-post: candidajoan@hotmail.com
Studieorter
-
-
Louisiana
-
Baton Rouge, Louisiana, Förenta staterna, 70808
- Rekrytering
- Pennington Biomedical Research Center
-
Kontakt:
- Candida J Rebello, PhD, RD
- Telefonnummer: 225-763-3159
- E-post: Candida.Rebello@pbrc.edu
-
Kontakt:
- Reilly Roberts A Project Manager, MS
- Telefonnummer: 225-763-2854
- E-post: Reilly.Roberts@pbrc.edu
-
-
Deltagandekriterier
Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.
Urvalskriterier
Åldrar som är berättigade till studier
- Vuxen
- Äldre vuxen
Tar emot friska volontärer
Nej
Beskrivning
Inclusion Criteria:
- Age > 50 years.
- Body mass index (BMI) ≥ 30 kg/m2.
- Homeostatic model assessment of insulin resistance ≥ 3.
- Mini-Mental State Examination (MMSE) > 25.
- Geriatric Depression Scale-15 (GDS-15) < 9.
- Sedentary (less than 90 minutes/week of moderate to vigorous activity).
- Ability to provide written informed consent.
Exclusion Criteria:
- Diagnosis of cancer (received within five years) or diabetes (type 1 and 2), or significant musculoskeletal, or cardiovascular, or hepatic, or renal, disease or dysfunction.
- Clinically significant gastrointestinal malabsorption syndromes such as chronic diarrhea, celiac disease, or clinically significant abnormal laboratory markers.
- Fluctuation in body weight > 3 kg in the preceding two months
- Condition that impedes testing of the study hypothesis or makes it unsafe to exercise or consume the study foods.
Studieplan
Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Behandling
- Tilldelning: Randomiserad
- Interventionsmodell: Parallellt uppdrag
- Maskning: Trippel
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Experimentell: Structured nutrition plan + exercise
Intervention: Participants receive a structured nutrition plan, and exercise under supervision.
|
Participants will receive a structured nutrition plan.
Participants will complete aerobic and resistance training under supervision three times per week.
|
|
Aktiv komparator: Typical or usual diet + exercise
Participants receive a typical or usual diet, and exercise under supervision
|
Participants will complete aerobic and resistance training under supervision three times per week.
Participants will receive a diet representing the usual diet in this population.
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Fat mass
Tidsram: Change from baseline to 12 weeks
|
Fat mass measured by dual X-ray absorptiometry
|
Change from baseline to 12 weeks
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Skeletal muscle mass
Tidsram: Change in from baseline to 12 weeks
|
Skeletal muscle mass will be measured by the creatine methyl D-3 dilution method
|
Change in from baseline to 12 weeks
|
|
Short physical performance battery
Tidsram: Change from baseline to 12 weeks
|
A test of physical function
|
Change from baseline to 12 weeks
|
|
Hand-grip strength
Tidsram: Change from baseline to 12 weeks
|
Hand grip strength will be measured using a hand dynamometer
|
Change from baseline to 12 weeks
|
|
Knee strength
Tidsram: Change from baseline to12 weeks
|
Knee strength will be measured quantified using Biodex dynamometry
|
Change from baseline to12 weeks
|
|
Energy stores
Tidsram: 12 weeks
|
Change in energy stores/day (kcal) determined from measures of body composition using the energy balance method
|
12 weeks
|
|
Hormonal regulation of energy balance
Tidsram: Change from baseline to 12 weeks
|
Blood concentrations of glucagon-like peptide 1
|
Change from baseline to 12 weeks
|
|
Hormonal regulation of energy balance
Tidsram: Change from baseline to 12 weeks
|
Blood concentrations of gastric inhibitory peptide
|
Change from baseline to 12 weeks
|
|
Hormonal regulation of energy balance
Tidsram: Change from baseline to 12 weeks
|
Blood concentrations of cortisol
|
Change from baseline to 12 weeks
|
|
Hormonal regulation of energy balance
Tidsram: Change from baseline to 12 weeks
|
Blood concentrations of leptin
|
Change from baseline to 12 weeks
|
|
Cardiorespiratory fitness
Tidsram: Change in VO2max from baseline to 12 weeks
|
VO2max
|
Change in VO2max from baseline to 12 weeks
|
Samarbetspartners och utredare
Det är här du hittar personer och organisationer som är involverade i denna studie.
Samarbetspartners
Utredare
- Huvudutredare: Candida J Rebello, PhD, RD, Pennington Biomedical Research Center
Studieavstämningsdatum
Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.
Studera stora datum
Studiestart (Faktisk)
20 juli 2026
Primärt slutförande (Beräknad)
1 december 2030
Avslutad studie (Beräknad)
1 december 2030
Studieregistreringsdatum
Först inskickad
8 maj 2026
Först inskickad som uppfyllde QC-kriterierna
14 maj 2026
Första postat (Faktisk)
20 maj 2026
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
3 september 2026
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
1 september 2026
Senast verifierad
1 juli 2026
Mer information
Termer relaterade till denna studie
Nyckelord
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- PBRC-2025-060
- 1R01AG092725-01A1 (U.S.S. NIH-anslag/kontrakt)
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
NEJ
IPD-planbeskrivning
At this time, we do not have plans to share IPD.
We may consider it after the study results have been publicly disseminated
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Nej
Studerar en amerikansk FDA-reglerad produktprodukt
Nej
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .